The largest database of trusted experimental protocols

4 protocols using ha k63

1

Plasmid Transfection for EIF3H Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
The wild-type and mutant constructs of EIF3H plasmids were purchased from the Hanbio Biotechnology Co., Ltd. (Shanghai, China). The HA-K48, HA-K63, and HA-Ub plasmids were acquired from Addgene. The small interfering RNAs targeting EIF3H (5ʹ-GCAACTCTTGGAAGAAATATA-3ʹ) and (5ʹ-CCCAAGGATCTCTCTCACTAA-3ʹ) were gained from Ruibo Biotechnology Co., Ltd. (Guangzhou, China). Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) was utilized for plasmid and siRNA transfection according to the manufacturer's recommendations.
+ Open protocol
+ Expand
2

Molecular Mechanisms of NRF2 Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
GFP‐polyQ74 (#40262), GFP‐p62 (#38277), GFP‐NRF2 (#21549), GFP‐KEAP1 (#28025), Flag‐KEAP1 (#28023), Myc‐NRF2 (#21555), Flag‐NRF2 (#36971), HA‐K48 (#17605), HA‐K63 (#17606), Flag‐ULK1 (#27636) were procured from Addgene. GFP‐TRIM16 and Flag‐TRIM16 were cloned as described previously (Chauhan et al, 2016). Myc‐TRIM16, Myc‐TRIM16 deletion constructs, and His‐K63‐UB were generated using Gateway cloning strategy as per standard protocol (Invitrogen).
The siRNA for NRF2 and p62 were purchased from Sigma, and TRIM16, Ubb, Ube2n siRNA were from Dharmacon. For overexpression experiments, HEK293T cells were transfected using calcium phosphate method as per the manufacturer's instructions (Profection, Promega). Other cells are transfected using Effectene (Qiagen) or Viafect (Promega) or Interference (Polyplus) as per the manufacturer's instruction.
+ Open protocol
+ Expand
3

Plasmids and siRNAs for Ubiquitin Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
The The full-length and deletion mutant constructs of TAZ and USP26 were obtained from Hanbio Biotechnology Co. Ltd. (Shanghai, China). The HA-K6, HA-K11, HA-K27, HA-K29, HA-K33, HA-K48, HA-K63, and HA-Ub plasmids were acquired from Addgene. Small interfering RNAs targeting USP26 (siRNA-1: 5′-GCACAAGACUUCCGUUGGA-3′; 5′-AAACAGAUCUGGUUCACUU-3′) were synthesized by Genepharma (Shanghai, China).
+ Open protocol
+ Expand
4

Characterization of NRF2-KEAP1 Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
GFP-polyQ74 (#40262), GFP-p62 (#38277), GFP-NRF2 (#21549), GFP-KEAP1 (#28025), Flag-KEAP1 (#28023), Myc-NRF2 (#21555), Flag-NRF2 (#36971), HA-K48 (#17605), HA-K63 (#17606), Flag-ULK1 (#27636) were procured from Addgene. GFP-TRIM16 and Flag-TRIM16 were cloned as described previously (Chauhan et al, 2016 (link)). Myc-TRIM16, Myc-TRIM16 deletion constructs, and His-K63-UB were generated using Gateway cloning strategy as per standard protocol (Invitrogen).
The siRNA for NRF2 and p62 were purchased from Sigma, and TRIM16, Ubb, Ube2n siRNA were from Dharmacon. For overexpression experiments, HEK293T cells were transfected using calcium phosphate method as per the manufacturer’s instructions (Profection, Promega). Other cells are transfected using Effectene (Qiagen) or Viafect (Promega) or Interference (Polyplus) as per the manufacturer’s instruction.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!